AliveCor

AI ECG for rapid cardiac diagnosis

Mountain View, California, United States

AliveCor specializes in cardiological care, utilizing portable ECG devices and AI to provide medical-grade heart data and detect various heart conditions.

Shareable draft

Check out AliveCor on @MedStartr Today AliveCor specializes in cardiological care, utilizing portable ECG devices and AI to provide medical-grade heart data and detect various heart conditions. #CardiovascularDisease #Neurology #CancerOncology #MedicalDevices #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/0IG2shibWIk

Get Involved in AliveCor

How We Help

Problem Statement

AliveCor aims to detect heart conditions such as Atrial Fibrillation, Bradycardia, Tachycardia, myocardial infarction, and ischemia, and provide cardiac safety monitoring.

Core Technology

ECG solutions

Key Differentiators

Portable ECG devices and AI to provide medical-grade heart data; Kardia 12L ECG System detects 39 cardiac conditions, including various arrhythmias and morphologies; Instrumental in identifying myocardial infarction and ischemia; Provides cardiac safety monitoring within clinical research across diverse therapeutic areas

Clinical Focus

Cardiological Care; Cardiac Safety Monitoring

Company Info

Business Model: Hybrid
Founded: 2011
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: alivecor.com/

Disease Areas

Cardiovascular Disease Neurology Cancer & Oncology

Technologies

Medical DevicesCardiac Monitoring & ECGTelehealth & TelemedicineHeart MonitoringDigital HealthWearable TechnologyMobile HealthAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

FDA 510(k) cleared devices; 39 FDA-cleared determinations; trained on 1.75M ECGs; Heart Rhythm O2 study: 29% faster acquisition; RCT: 56% AFib diagnosis in 9.5 days

🌐Website

MedStartr Engagement Score

Too Big!

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of AliveCor?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.